An Investigator Initiated, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of Humira (Adalimumab) For The Treatment of Interstitial Cystitis(IC).

Trial Profile

An Investigator Initiated, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of Humira (Adalimumab) For The Treatment of Interstitial Cystitis(IC).

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Jul 2015

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Interstitial cystitis
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 25 Aug 2013 Status changed from active, no longer recruiting to completed.
    • 20 Jun 2013 Results published in the Journal of Urology.
    • 11 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top